期刊文献+

22055名中老年男性前列腺特异性抗原及相关参数的年龄特异性分析 被引量:10

Analysis of age-specific prostate specific antigen and related parameters in 22 055 elderly men
原文传递
导出
摘要 目的明确我国中老年男性前列腺特异性抗原(PSA)及相关参数的年龄特异性正常参考值。方法对2007年4月至2011年11月我院体检中心22055名≥40岁男性血清PSA结果进行统计分析,以10岁为组距分成5组,记录总PSA(tPSA)、游离PSA(fPSA)、前列腺B超等结果,计算游离-总PSA比值(f/t)、PSA密度(PSAD)、PSA速率(PSAV)。百分位数P95视为某参数的正常值上限,百分位数P5视为正常值下限。结果tPSA与年龄呈正相关(r=O.349,P〈0.001)。f/t与年龄呈负相关(r=-0.154,P〈0.001),尽管各年龄组间f/t不尽相同(P〈0.001),然而各组P5均为0.18。〈70岁和≥70岁者PSAD差异有统计学意义(P〈0.001),P95分别为0.09和0.15,与年龄呈正相关(r=0.263,P〈0.01)。〈60岁与≥60岁PSAV差异有统计学意义(P〈0.001),P95分别为0.21和0.58,与年龄呈正相关(r=0.130,P〈0.01)。结论PSA、PSAD、PSAV与年龄呈正相关,而f/t与年龄呈负相关。我国男性f/t的正常范围是0.18~1.00,对40岁以上者适用。〈70岁和≥70岁男性PSAD正常值分别为〈0.09和〈0.15。〈60岁和≥60岁男性PSAV正常值分别为〈0.21和〈0.58。 Objective To define the age-specific normal reference, yalues of prostate specific antigen (PSA) and related parameters in Chinese middle-aged and elderly men. Methods From April 2007 to November 2011, serum PSAs of over 22 055 men aged more than 40 years old in our medical examination center were statistically analyzed. The men was divided into five groups by a 10-year-old interval. Total PSA (tPSA) , free PSA (fPSA) and prostate ultrasound results were recorded. The free-total PSA ratio (f/t) , PSA density (PSAD) and PSA velocity (PSAV) were calculated. By convention, the 95th percentile (P95) was used as the upper limit value, and the 5th percentile (PS) as the lower limit value. Results The tPSAs were positively correlated with age (r= 0.349, P〈0.001). f/t was negatively correlated with age (r= -0.154, P〈0.01). Although f/t was significantly different (P〈0.001) among each age group, P5 of all groups were 0.18. PSAD was significantly different (P〈0.001) between men over and under 70 years, with P95 as 0.09 and 0.15, respectively. PSAD had a positive correlation with age (r = 0.263, P〈0.01). The significant difference of PSAV raised between men over and under 60 years, with P95 as 0.21 and 0.58, respectively. PSAV was positively correlated with age (r= 0.130, P〈0.01). Conclusions PSA, PSAD and PSAV are positively correlated with age, while f/t is negatively correlated with age. The normal range of flit is 0.18-1.00 for Chinese men over 40 years old. PSAD's normal ranges are 〈0.09 and 〈0.15 in Chinese men over and under 70 years, respectively. The normal range of PSAV are 〈0.21 and 〈0.58 for Chinese men over and under 60 years, respectively.
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2013年第8期613-617,共5页 Chinese Journal of Urology
关键词 前列腺特异抗原 年龄特异性 游离-总PSA比值 PSA密度 PSA速率 Prostate-specific antigen Age-specific Free-total PSA ratio PSA density PSA
  • 相关文献

参考文献13

  • 1Matthew BG, Alan WP. PSA levels and the probability of pros- tate cancer on biopsy. Eur Uro Suppl, 2002, 1: 21-27.
  • 2Walsh PC, Oesterling JE, Epstein ..ll, et al. The value of pros- tate-specific antigen in the management of localized prostatic cancer. Prog Clin Biol Res, 1989, 303: 27-33.
  • 3Wu 'IT, Huang JK. The clinical usefulness of prostate-specific antigen (PSA) level and age-specific PSA reference ranges for detecting prostate cancer in Chinese. Urol Int, 2004, 72: 208- 211.
  • 4Catalona WJ, Southwick PC, Slawin KM, et al. Comparison ofpercent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging. Urology, 2000, 56: 255- 260.
  • 5Tang P, Du W, Xie K, et al. Characteristics of baseline PSA and PSA velocity in young men without prostate cancer: racial differences. Prostate, 2012, 72: 173-180.
  • 6Oesterling JE, Jacobsen SJ, Chute CG, et al. Serum prostate- specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA, 1993, 270, 860-864.
  • 7Bo M, Ventura M, Marinello R, et al. Relationship between prostatic specific antigen (PSA) and volume of the prostate in the benign prostatic hyperplasia in the elderly. Crit Rev Oncol Hematol, 2003, 47 : 207-211.
  • 8Kalish LA, McKinlay JB. Serum prostate-specific antigen levels (PSA) in men without clinical evidence of prostate cancer: age- specific reference ranges for total PSA, free PSA, and percent free PSA. Urology, 1999, 54: 1022-1027.
  • 9Stephan C, Lein M, Jung K, et al. The influence of prostate vo- lume on the ratio of free to total prostate specific antigen in serum of patients with prostate carcinoma and benign prostate hyperpla- sia. Cancer, 1997, 79: 104-109.
  • 10Carter HB, Ferrucci L, Kettermann A, et al. Detection of life- threatening prostate cancer with prostate-specific antigen velocity during a window of curability. J Natl Cancer Inst, 2006, 98: 1521-1527.

二级参考文献16

  • 1张思维,陈万青,孔灵芝,李连弟,鲁凤珠,李光琳,孟佳,赵平.中国部分市县1998~2002年恶性肿瘤的发病与死亡[J].中国肿瘤,2006,15(7):430-448. 被引量:171
  • 2李连弟,饶克勤.中国试点市县恶性肿瘤的发病与死亡第1卷(1988-1992).北京:中国医药科技出版社,2002:263-289.
  • 3李连弟,饶克勤.中国试点市县恶性肿瘤的发病与死亡第2卷(1993-1997).北京:中国医药科技出版社,2003:269-295.
  • 4李连弟,饶克勤,孔灵芝,等.中国试点市县恶性肿瘤的发病与死亡第3卷(1999-2002).北京:人民卫生出版社,2007:314-316.
  • 5Parkin DM, Whelan SL, Ferlay J, et al. Cancer incidence in five continents. Vol. VIII. IARC Scientific Publication No. 155. Lyon: IARC, 2002: 745-747.
  • 6Curado MP, Edwards B, Shin HR, et al. Cancer incidence in five continents. Vol. IX. IARC Scientific Publication No. 160. Lyon: IARC, 2008.
  • 7Jensen OM, Parkin DM, MacLennan R, et al. Cancer registration: principles and methods. IARC Scientific Publication No. 95. Lyon.. IARC, 1991.. 101-107.
  • 8Parkin DM, Chen VW, Ferlay J, et al. Comparability and quality control in cancer registration. IARC Technical Report No. 19. Lyon.. IARC, 1994: 35-49.
  • 9Felay J, Burkhard C, Whelan S, et al. Check and conversion programs for cancer registries. IARC Technical Report No. 42. Lyon: IARC, 2005: 11-38.
  • 10Felay J. The IARCcrgTools program, http://www, iacr. com. fr/iarccrgtools, htm. IACR. Lyon. 2006.

共引文献238

同被引文献78

引证文献10

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部